Recruitment site Lagou received USD 120M for series D from 51Job
Founder: Xu Dandan
Founded in: 2013
Financing status: RMB 789 million (USD 120 million) for Series D financing round in 2017
Recruitment site, Lagou, received USD 120 million for series D from 51Job on September 22 to prepare for an IPO in the U.S.
Lagou is a recruitment site that connects tech talent to companies to facilitate the recruitment process. Lagou runs a back-end payment model, which allows HR to post positions and job seekers to browse jobs free of charge. Payment only applies to employers who have recruited successfully.
Founded in 2013 in Beijing, two years ago, after four years of development, the company launched commercialization plans and claimed to have more than tens of millions in RMB of revenue from its recruitment businesses. According to Lagou, it has more than 250,000 enterprises uploading their job positions on Lagou’s site, as well as over 10 million tech practitioners seeking jobs on Lagou.
This new financing round was led by 51Job, a Chinese HR service provider. It has famous existing investors including Xu Xiaoping, founder of ZhenFund, Bertelsmann Asia Investments, Qiming Venture Partners, and so on. Lagou plans to use the funds to cooperate with 51Job by sharing 51Job’s resources on customers to expand its business in order to increase profit, as well as prepare for an IPO in the U.S. in 2019.
Medical image diagnosis company Infervision received USD 18M for Series B
Founder: Chen Kuan
Founded in: 2014
Financing status: RMB 120 million (USD 18 million) for Series B financing in 2017
Medical image diagnosis company, Infervision, received USD 18M for Series B on September 21 to speed up the commercialization of medical image diagnoses.
Infervision is a medical image diagnosis company that applies artificial intelligence and deep learning technology to assist medical image diagnosis. It uses various types of medical data to create clinically valued products and promotes precision analysis in the medical field especially in assisted image diagnosis. It also analyzes and compares corresponding clinical materials, including clinical reports and laboratory statistics, in order to discover the connection behind the data and provide patients with precise medical solutions.
Founded in 2014 in Shanghai, it currently has products for early lung cancer screening, cardiothoracic detection, medical data modeling, and so on. It is seeking cooperation with hospitals and medical organizations to promote its medical solutions. Meanwhile, it can collect more data for precise solutions.
This new financing round was led by a group of investors, including Qiming Venture Partners, Genesis Capital, and Sequoia Capital China. This is the largest single financing round in the international medical image artificial intelligence industry. The capital will be used to speed up the commercialization of medical image diagnosis, as well as invest in overseas market expansion plans.
（Top photo from 699pic.com）